We are excited to announce that this year's Plasma Protein Forum is November 19-20! Registration opens in one month on September 9. Bookmark the event page here:
This content isn’t available here
Access this content and more in the LinkedIn app
The Plasma Protein Therapeutics Association (PPTA) represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma used for fractionation. As a trusted partner to health systems, PPTA drives broad and reliable access to plasma derived medicinal products with a focus on the well-being of patients and plasma donors. These therapies are used by small patient populations worldwide to treat a variety of rare diseases and serious medical conditions. PPTA works globally to: • Advocate for access to and affordability of therapies for patients • Engage in constructive dialogue with regulatory agencies • Collaborate with patient advocacy organizations PPTA also administers standards and programs that help ensure the quality and safety of plasma collection and manufacturing and protect both donors and patients. PLASMA AVAILABILITY • Responsibly Improve the Reliable Availability of Plasma • Advocate for global sufficiency of plasma • Pioneer plasma safety and manufacturing quality and support donor well-being • Drive progressive policies for plasma collections ACCESS TO THERAPIES • Advocate for Patient Access to Plasma Protein Therapies • Promote clinician authority and patient participation in treatment • decisions • Pursue reimbursement models recognizing the unique nature of plasma protein therapies • Shape decisions of authorities to improve plasma protein therapy availability • Forage partnerships that support patient-focused initiatives AWARENESS • Advance the Understanding of the Plasma Ecosystem • Encourage plasma donation globally • Generate and promote evidence-based information about plasma • Explain the importance, unique nature, and value of plasma protein therapies
External link for Plasma Protein Therapeutics Association (PPTA)
147 Old Solomons Island Road
Suite 100
Annapolis, MD 21401, US
Congratulations to the following plasma centers on achieving IQPP certification! IQPP provides independent, third-party evaluation, and recognition of a center's adherence to global industry standards for source plasma. Click here to learn more: https://lnkd.in/eFTi4kHq
"What I like about plasma donation is that it is an easy way to help others, since almost everyone who is healthy can do it. It does not take a lot to give — just a little of your time." Hear more from plasma donor Monika in the latest addition of The Source Magazine: https://bit.ly/3WMVQ2k
Join us in celebrating National Nonprofit Day! Today, we honor the incredible efforts of nonprofit organizations. At PPTA, we are proud to work with the many patient advocacy groups that work tirelessly to raise public awareness of the rare diseases that require plasma-derived therapies and make a positive impact on their communities. You can learn more about these important organizations here: https://lnkd.in/ecq3TwFZ
📢 PLASMA IS UNIQUE 📢 Plasma-derived medicines and pharmaceuticals are not the same. Plasma cannot be made in a laboratory and depends solely on donations from healthy individuals. PLUS, it can take up to 12 months for a donation to become a plasma-derived therapy. Learn more at https://lnkd.in/ebR4nhUY
The new International Plasma Awareness Week website is coming soon! We are just a few weeks away from the launch of https://lnkd.in/et25pc3t. Save the URL now and visit in a few weeks to download free toolkits and resources to raise awareness for plasma users and donors. #IPAW2024 takes place Oct. 7-11.
The new International Plasma Awareness Week website is coming soon! We are just one week away from the launch of https://lnkd.in/et25pc3t. Save the URL now and check back on August 20th for free toolkits and information to raise awareness for plasma users and donors. #IPAW2024 takes place Oct. 7-11.
This week, PPTA's Vice President of Government Affairs, Sharon Pearce, traveled with members to the Grifols' manufacturing campus in Clayton, North Carolina, which produces plasma-derived medicines and other biopharmaceutical solutions that treat patients with chronic, rare and, at times, life-threatening conditions. Thank you to the Grifols' team for organizing an informative visit.